TEVA-NAPROXEN EC
TEVA CANADA LIMITED
Quick answers
Is there a shortage of TEVA-NAPROXEN EC in Canada?
No. There is no current shortage of TEVA-NAPROXEN EC 250MG reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Other Products
NAPROSYN 250MG
SYNTEX INC.
NU-NAPROX TAB 250MG
NU-PHARM INC
NAPROSYN 375MG
SYNTEX INC.
RATIO-NAPROXEN
RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED
SYNFLEX TAB 275MG
ALTIMED PHARMA INC.
ANAPROX
SYNTEX INC.
DIN
02243312
Strength
250MG
Dosage Form
Tablet (Enteric-Coated)
Route
Oral
Compare with another product →
Shortage History
No shortage or discontinuation reports on file for this product.
Other Products from TEVA CANADA LIMITED
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
DIN 02143933
DIN 00834319
3.5MG · DIN 02438399
0.5MG · DIN 02301407
100MG · DIN 02420155
200MG · DIN 02420163
500MG · DIN 02247340
750MG · DIN 02247341
250MG · DIN 02247339
75MG · DIN 02303027
180MG · DIN 02370638
240MG · DIN 02370646